Due to absence of validated biomarkers of IBD disease monitoring, our finding provides a useful tool to monitor the status of the colonic mucosa using identification of Lept, Ob-R and GLUT5 molecules. This evidence concerns the gene LEPR and irritable bowel syndrome.